newsfilter
← Latest News
GlobeNewswire·

Evelo Biosciences to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022

CAMBRIDGE, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, today announced tha